Wockhardt Offer to Government: Indian pharmaceutical company Wockhardt has told the Government of India that it has the capacity to produce 500 million vaccines by February 2022. At the same time, the company can produce 2 billion doses i.e. 200 crore vaccine doses in a year. The company has told the government that it has manufacturing and research capabilities to create a diversified portfolio, which will allow it to produce and supply protein-based and viral vector-based vaccines. At the same time, the government is investigating the company’s offer.
Offer to central government
According to the report of The Indian Express, the company has formally proposed this to the central government. Wockhardt has sought help in identifying potential allies in the country whose vaccines he can produce. According to the report, the company has told the government that it can produce the vaccine present in the market. Along with this, the process of acquiring the technology needed to make his vaccine is going on. According to the company, it can produce and research all three types of vaccines based on mRNA, protein based and viral sector.
According to the report, Wockhardt can quickly establish the capacity to produce 500 million doses of any COVID vaccine annually. It may take 6 to 9 months to install this capability. According to sources, talks are going on with Wockhardt’s companies. There may be an agreement with an international company in the coming time.
Already Deal with UK Government
However, outside India, Wockhardt has already entered into an agreement with the UK government to make the COVID 19 vaccine exclusively for the UK. Due to this, Wockhardt AstraZeneca is preparing Oxford University’s vaccine to be filled in vials and used in the country’s vaccination program.
Government is considering
According to the information, the government is considering this offer of the company as there is already an agreement with the UK government to ‘fill and finish’ the COVID-19 vaccines specifically for the United Kingdom. The company is currently operating from its plant in North Wales. Earlier in a program, Minister of State for Chemicals and Fertilizers Mansukh L. Mandavia also said that Wockhardt had told last week that he wanted to tie up with any company (for the manufacture of COVID-19). So, we are working on it as well. We will get them tied up with a company.